GCA
EW icon

Genesee Capital Advisors’s Edwards Lifesciences EW Stock Holding History

Genesee Capital Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,709
Closed -$1.79M – 84
2022
Q3 		$1.79M Sell
21,709
-647
-3% -$62.3K 1.37% 16
2022
Q2 		$2.13M Sell
22,356
-2,890
-11% -$299K 1.49% 16
2022
Q1 		$2.97M Sell
25,246
-364
-1% -$40.8K 1.55% 15
2021
Q4 		$3.32M Sell
25,610
-636
-2% -$74.2K 1.58% 15
2021
Q3 		$2.97M Buy
+26,246
New +$3M 1.47% 18
2021
Q2 		– Sell
-26,860
Closed -$2.25M – 69
2021
Q1 		$2.25M Buy
26,860
+3,145
+13% +$266K 1.33% 21
2020
Q4 		$2.16M Buy
23,715
+33
+0.1% +$2.74K 1.42% 24
2020
Q3 		$1.89M Sell
23,682
-326
-1% -$25.4K 1.56% 19
2020
Q2 		$1.66M Sell
24,008
-3,862
-14% -$274K 1.54% 22
2020
Q1 		$1.75M Sell
27,870
-8,634
-24% -$623K 1.68% 15
2019
Q4 		$2.84M Sell
36,504
-786
-2% -$61.4K 2.42% 7
2019
Q3 		$2.73M Sell
37,290
-99
-0.3% -$6.95K 2.53% 7
2019
Q2 		$2.3M Sell
37,389
-1,368
-4% -$82.7K 2.32% 9
2019
Q1 		$2.47M Buy
38,757
+2,202
+6% +$126K 2.97% 7
2018
Q4 		$1.87M Buy
+36,555
New +$1.85M 3.05% 7

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Genesee Capital Advisors's EW Position: Q4 2022 in Review

Genesee Capital Advisors sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 21,709 shares — an estimated $1.79M sold.

Genesee Capital Advisors first reported a position in EW in Q4 2018 and held it in 15 quarters. The position peaked at $3.32M in Q4 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

  • Genesee Capital Advisors reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
  • Genesee Capital Advisors sold 21,709 Edwards Lifesciences shares in Q4 2022, an estimated $1.79M.
  • Genesee Capital Advisors first reported a position in Edwards Lifesciences in Q4 2018 and held it in 15 quarters.
  • Genesee Capital Advisors's Edwards Lifesciences position peaked at $3.32M in Q4 2021.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Genesee Capital Advisors's 13F filing for Q4 2022, filed 20 Jan 2023.